title: Can sugammadex encapsulation eliminate the antigenic activity of aminosteroidal neuromuscular blocking agent?
authors: Takashi
authors: T
authors: Kawano
authors: Masataka
authors: M
authors: Yokoyama
mesh_terms: D000707:Anaphylaxis / Q000139:chemically induced / Q000276:immunology; D000758:Anesthesia / Q000009:adverse effects; D004347:Drug Interactions; D000939:Epitopes / Q000276:immunology; D006801:Humans; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000737:chemistry / Q000494:pharmacology; D000077122:Sugammadex; D047408:gamma-Cyclodextrins / Q000009:adverse effects / Q000737:chemistry* / Q000494:pharmacology*
chemical_list: D000939:Epitopes; D009466:Neuromuscular Blocking Agents; D000644:Quaternary Ammonium Compounds; D047408:gamma-Cyclodextrins; D000077122:Sugammadex